Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Tai Chi and cognitive behavioral therapy can reduce insomnia, inflammation in breast cancer survivors

New research led by UCLA Health confirms that both Tai Chi and cognitive behavioral therapy can reduce insomnia in breast cancer survivors but also may provide additional health benefits by reducing inflammation and bolstering anti-viral defenses.

26 Jun 2024

Chemotherapy's cognitive side effects tied to gut microbiome disruption

Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition.

26 Jun 2024

Ground falls most common cause of head injury in elderly, new study finds

Falls are the most common cause of injury among adults 65 and older in the United States. According to the U.S. Centers for Disease Control and Prevention, every year, more than 14 million older adults (one in four) report a fall. About 90% of head injuries among older individuals is due to ground-level falls.

26 Jun 2024

Mouse studies suggest gestational CBD exposure alters offspring behavior and brain function

Cannabidiol (CBD), one of the active ingredients in cannabis, is thought to be safe as it does not cause a "high".

24 Jun 2024

CAMH research suggests potential targets for prevention and early identification of psychotic disorders

A new study by the Centre for Addiction and Mental Health (CAMH), entitled Mental Health Service Use Before First Diagnosis of a Psychotic Disorder and published in JAMA Psychiatry, found that nearly 75 per cent of young Ontarians with a psychotic disorder had at least one mental health service visit within the three years prior to their first diagnosis of the disorder.

21 Jun 2024

Cannabis use tied to increased risk of severe COVID-19

As the deadly disease that came to be known as COVID-19 started spreading in late 2019, scientists rushed to answer a critical question: Who is most at risk?

21 Jun 2024

One copy of the Christchurch variant may confer protection against familial Alzheimer's disease

A scientific story that began with a discovery in just one extraordinary patient is now panning out. In 2019, an international team that included researchers from two Mass General Brigham hospitals -; Mass Eye and Ear and Massachusetts General Hospital (MGH)-; reported on the case of a patient who did not develop cognitive impairment until her late 70s, despite being part of a family at extremely high genetic risk for developing early-onset Alzheimer's disease.

20 Jun 2024

Impact of family history on developmental outcomes in siblings of children with autism

Children who have an older sibling with autism spectrum disorder (autism) are at greater risk of developmental vulnerabilities if they also have other relatives with neurodevelopmental or psychiatric conditions, according to a new study from the Yale Child Study Center.

19 Jun 2024

Is coffee good or bad? Genetic study investigates health correlations

Coffee drinking is a heritable habit, and one that carries a certain amount of genetic baggage.

18 Jun 2024

Blood test identifies specific pathologies in frontotemporal dementia, ALS, and PSP

In a study with 991 adults, scientists at DZNE show that the most common forms of frontotemporal dementia (FTD) as well as the neurological diseases amyotrophic lateral sclerosis (ALS) and progressive supranuclear palsy (PSP) can be recognized by blood testing.

18 Jun 2024

Older women are different than older men. Their health is woefully understudied.

Medical research has shortchanged women for decades. This is particularly true of older women, leaving physicians without critically important information about how to best manage their health.

18 Jun 2024

Stanford study identifies six depression biotypes for personalized treatment

In the not-too-distant future, a screening assessment for depression could include a quick brain scan to identify the best treatment.

17 Jun 2024

Study reveals why EGFR inhibitors fail in some non-smokers with lung cancer

The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the Francis Crick Institute and AstraZeneca.

13 Jun 2024

New diagnosis proposed for the spectrum of gaming-related health issues

University of Queensland researchers are suggesting a new diagnosis should be added to the official world diseases list to better identify those with gaming disorders.

13 Jun 2024

Study highlights benefits of ADHD medications for pregnant patients with opioid use disorder

Opioid overdoses for pregnant patients are at an all-time high in the United States, even as overall numbers are improving.

13 Jun 2024

New psychotherapy shows promise in reducing chronic pain for older veterans

A new study led by UCLA Health and the U.S. Veterans Affairs Office found chronic pain among older adults could be significantly reduced through a newly developed psychotherapy that works by confronting past trauma and stress-related emotions that can exacerbate pain symptoms.

13 Jun 2024

Research points to a potential approach to mitigating diabetes risk from antipsychotic medications

New University of Pittsburgh research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications.

13 Jun 2024

Approximately 1 in 6 patients experience antidepressant withdrawal symptoms, systematic review finds

Researchers performed a meta-analysis to determine the prevalence of antidepressant discontinuation symptoms.

13 Jun 2024

UCL researchers identify brain mechanisms behind mood bias in bipolar disorder

Momentary shifts in mood, even those lasting just a matter of seconds, profoundly alter the brain's response to pleasurable experiences in people with bipolar disorder, finds a new study by UCL researchers.

12 Jun 2024

Few UK Alzheimer's patients suitable for new disease-modifying drugs, study finds

Few people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

11 Jun 2024

Psychiatry News and Research

Further Reading

Tai Chi and cognitive behavioral therapy can reduce insomnia, inflammation in breast cancer survivors

Chemotherapy's cognitive side effects tied to gut microbiome disruption

Ground falls most common cause of head injury in elderly, new study finds

Mouse studies suggest gestational CBD exposure alters offspring behavior and brain function

CAMH research suggests potential targets for prevention and early identification of psychotic disorders

Cannabis use tied to increased risk of severe COVID-19

One copy of the Christchurch variant may confer protection against familial Alzheimer's disease

Impact of family history on developmental outcomes in siblings of children with autism

Is coffee good or bad? Genetic study investigates health correlations

Blood test identifies specific pathologies in frontotemporal dementia, ALS, and PSP

Older women are different than older men. Their health is woefully understudied.

Stanford study identifies six depression biotypes for personalized treatment

Study reveals why EGFR inhibitors fail in some non-smokers with lung cancer

New diagnosis proposed for the spectrum of gaming-related health issues

Study highlights benefits of ADHD medications for pregnant patients with opioid use disorder

New psychotherapy shows promise in reducing chronic pain for older veterans

Research points to a potential approach to mitigating diabetes risk from antipsychotic medications

Approximately 1 in 6 patients experience antidepressant withdrawal symptoms, systematic review finds

UCL researchers identify brain mechanisms behind mood bias in bipolar disorder

Few UK Alzheimer's patients suitable for new disease-modifying drugs, study finds

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News